Is anyone else following this stock? I feel like I'm all alone out here, this time with 2 items of good news.
Dow Jones Newswires -- January 5, 1998
Chiroscience Group Begins Phase I Trials Of Cancer Inhibitor
Dow Jones Newswires
LONDON -- Chiroscience Group PLC's D2163, a cancer treatment,
entered phase I clinical trials.
In a press release Monday, the company said D2163, part of the class of drugs known as MMP inhibitors, checks the growth of enzymes thought to be important to the spread of cancer.
Chiroscience said the drug doesn't cause the side effects, such as joint pain and tendonitis, of first-generation MMP inhibitors.
The U.K. pharmaceutical company said it expects to start phase I trials of its other MMP inhibitor, D1927, before the end of the first quarter.
Copyright c 1998 Dow Jones & Company, Inc. All Rights Reserved.
Dow Jones Newswires -- January 6, 1998
Chiroscience Shares Up 4.2% After Merrill Lynch 'Buy' Rating
AP-Dow Jones News Service
LONDON -- Shares in U.K. pharmaceuticals group Chiroscience Group
PLC (U.CCC) are up more than 4% following an initial 'buy' rating by
London-based securities house Merrill Lynch Tuesday.
At 1435 GMT, Chiroscience shares were up 10 pence, or 4.2%, at 247.5
pence a share, on volume of 651,416 shares.
Copyright c 1998 Dow Jones & Company, Inc. All Rights Reserved. |
